Final ID: 88
Ko Kyunga, Cohen Roger, Hutton Sandra, Jabbour Salma, Jung Wonyoung, Keltz Jonathan, Mak Raymond, Nagda Suneel, Ohri Nitin, Robinson Clifford, Smith Amanda, Yegya-raman Nikhil, Sun Lova, Soike Michael, Walls Gerard, Wang Jessica, Feigenberg Steve, Ky Bonnie, Han Ivy, Mitchell Joshua, Zou Wei, Levin William, Barrett Leanne, Bravo Paco, Di Carli Marcelo
A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid AngiopathyGreenberg Steven, Parikh Neal, Lee Jin-moo, Van Etten Ellis, Van Osch Matthias, Klijn Catharina, Sostelly Alexandre, Goteti Sasikiran, Sepehrband Farshid, Avbersek Andreja, Deering Robert
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.